Patents by Inventor FAWZI ABDALLA BABIKER

FAWZI ABDALLA BABIKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preventing myocardial reperfusion injury in reperfusion therapy by administering intravenous immunoglobulin
    Patent number: 10087238
    Abstract: The method of preventing reperfusion injury in reperfusion therapy is a medical technique for prevention of reperfusion injury in a patient where reperfusion therapy is necessary, such as following myocardial infarction (MI) or heat transplant in the patient. The patient is treated with intravenous immunoglobulin (IVIG) prior to an ischemic event or, alternatively, following the ischemic event, with the intravenous immunoglobulin providing cardio-protective effects to the patient for preventing reperfusion injury. The treatment with the IVIG may be used with any suitable type of reperfusion therapy, such as thrombolytic therapy, coronary angioplasty or coronary artery bypass surgery.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: October 2, 2018
    Assignee: KUWAIT UNIVERSITY
    Inventors: Waleed Ebrahim Al-Herz, Fawzi Abdalla Babiker
  • METHOD OF PREVENTING REPERFUSION INJURY IN REPERFUSION THERAPY
    Publication number: 20180237500
    Abstract: The method of preventing reperfusion injury in reperfusion therapy is a medical technique for prevention of reperfusion injury in a patient where reperfusion therapy is necessary, such as following myocardial infarction (MI) or heat transplant in the patient. The patient is treated with intravenous immunoglobulin (IVIG) prior to an ischemic event or, alternatively, following the ischemic event, with the intravenous immunoglobulin providing cardio-protective effects to the patient for preventing reperfusion injury. The treatment with the IVIG may be used with any suitable type of reperfusion therapy, such as thrombolytic therapy, coronary angioplasty or coronary artery bypass surgery.
    Type: Application
    Filed: February 22, 2017
    Publication date: August 23, 2018
    Inventors: WALEED EBRAHIM AL-HERZ, FAWZI ABDALLA BABIKER